Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-12-12
1992-09-29
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514929, 514964, A61K 3144
Patent
active
051514346
ABSTRACT:
A controlled-release pharmaceutical preparation of 3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine. The controlled-release preparation is in the form of powder or granule containing 3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine, coated with medically non-active substance or in the form of rectal suppository containing 3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine. Further the controlled-release is prepared by implanting 3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine in fatty materials, or granulating it and coating the resultant particles with medically non-active substance.
REFERENCES:
patent: 4540566 (1985-09-01), Davis et al.
patent: 4548490 (1985-10-01), Mueller et al.
Chemical Abstracts 93:155800e (1980).
Imai Jun
Irikura Tsutomu
Komuro Masakatsu
Uchida Hirohsi
Kyorin Seiyaku Kabushiki Kaisha
Schenkman Leonard
LandOfFree
Controlled-release composition and the preparation thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled-release composition and the preparation thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled-release composition and the preparation thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1968773